Gastroenterology
Gastrointestinal cancer postoperative outcome improved by preoperative enteral immunonutrition
Published in Gastroenterology Week, September 18th, 2006
"The purpose of this study was to evaluate the effect of preoperative immunonutrition pharmaceutics (IMPACT) diet versus standard enteral nutrition (EN) on the nutritional status and immunity of patients with colorectal or GI cancer and to evaluate whether it influences the incidence of postoperative complication. Sixty patients with GI cancer were randomly divided into 2 groups, IM and control diet (CT), each of which was fed with IMPACT and conventional diet,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Colon Cancer
Colon cancer sensitivity to gefitinib is restored upon insulin receptor isoform-A blockade - Crohn Disease
MAP/self-mimics as targets of cross-reactive antibody responses in Crohn disease - Gastroenterology
Rectal giant adenomas can be resected using transanal endoscopic microsurgery - Pancreatic Cancer
Pancreatic neoplasia was more frequent in high-risk individuals with EUS and ERCP abnormalities - Adverse Drug Reaction
Onercept evaluated for use in moderate-to-severe Crohn's disease - Adverse Drug Reaction
Patient toxicity from 5-FU chemotherapy predicted by OPRT gene polymorphism - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
